Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex

US9802936B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9802936-B2
Application numberUS-86947407-A
CountryUS
Kind codeB2
Filing dateOct 9, 2007
Priority dateJul 5, 2002
Publication dateOct 31, 2017
Grant dateOct 31, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

This invention relates to a method to modulate exogenous gene expression in which an ecdysone receptor complex comprising: a DNA binding domain; a ligand binding domain; a transactivation domain; and a ligand is contacted with a DNA construct comprising: the exogenous gene and a response element; wherein the exogenous gene is under the control of the response element and binding of the DNA binding domain to the response element in the presence of the ligand results in activation or suppression of the gene. The ligands comprise a class of ketones.

First claim

Opening claim text (preview).

What we claim is: 1. A compound of formula I: wherein Q 1 is selected from the group consisting of O and S; R 1 is selected from the group consisting of 2-methyl-3,4-methylenedioxyphenyl, 2-ethyl-3,4-methylenedioxyphenyl, 2-methyl-3,4-ethylenedioxyphenyl, 2-ethyl-3,4-ethylenedioxyphenyl, and 2-methyl-3,4-oxydimethylenephenyl; R 2 and R 3 are independently: (a) cyano, aminocarbonyl, carboxy, (C 1 -C 6 )alkyl, (C 3 -C 6 )cycloalkyl, halo(C 1 -C 6 )alkyl, (C 3 -C 6 )halocycloalkyl, (C 2 -C 6 )alkenyl, (C 3 -C 6 )cycloalkenyl, (C 2 -C 6 )haloalkenyl, (C 2 -C 6 )alkynyl, (C 1 -C 6 )alkylsulfonyl, (C 1 -C 6 )alkoxy(C 1 -C 6 )alkyl, (C 1 -C 6 )alkylthio(C 1 -C 6 )alkyl, (C 1 -C 6 )alkylsulfinyl(C 1 -C 6 )alkyl, (C 1 -C 6 )alkylsulfonyl(C 1 -C 6 )alkyl, (C 1 -C 6 )alkylamino(C 1 -C 6 )alkyl, di(C 1 -C 6 )alkylamino(C 1 -C 6 )alkyl, (C 1 -C 6 )alkylcarbonyl, (C 1 -C 6 )alkylcarbonyl(C 1 -C 6 )alkyl, (C 1 -C 6 )alkylaminocarbonyl, di(C 1 -C 6 )alkylaminocarbonyl, (C 1 -C 6 )alkylaminocarbonyl(C 1 -C 6 )alkyl, di(C 1 -C 6 )alkylaminocarbonyl(C 1 -C 6 )alkyl, (C 1 -C 6 )alkylcarbonylamino(C 1 -C 6 )alkyl, (C 1 -C 6 )alkoxycarbonyl, (C 1 -C 6 )alkoxycarbonyl(C 1 -C 6 )alkyl, cyano(C 1 -C 6 )alkyl, hydroxy(C 1 -C 6 )alkyl, or carboxy(C 1 -C 6 )alkyl; or (b) unsubstituted or substituted phenyl, phenyl(C 1 -C 6 )alkyl, benzoyl, naphthyl, pyridyl, pyrazinyl, pyridazinyl, pyrimidinyl, furanyl, thiophenyl, benzothiophenyl, benzofuranyl, isoxazolyl, or imidazolyl, heterocyclylcarbonyl, wherein the substituents are independently selected from the group consisting of cyano, nitro, halo, aminocarbonyl, aminothiocarbonyl, carboxy, formyl, hydroxy, amino, carbamoyl, (C 1 -C 3 )alkyl, (C 1 -C 3 )haloalkyl, (C 1 -C 3 )alkoxy, (C 1 -C 3 )haloalkoxy, (C 1 -C 3 )alkythio, (C 1 -C 3 )haloalkylthio, (C 1 -C 3 )alkylsulfonyl, (C 1 -C 3 )alkylamino, di(C 1 -C 3 )alkylamino, (C 1 -C 2 )alkoxy(C 1 -C 2 )alkyl, (C 1 -C 2 )alkylthio(C 1 -C 2 )alkyl, (C 1 -C 2 )alkylsulfonyl(C 1 -C 2 )alkyl, (C 1 -C 2 )alkylamino(C 1 -C 2 )alkyl, di(C 1 -C 2 )alkylamino(C 1 -C 2 )alkyl, (C 1 -C 3 )alkylcarbonyl, (C 1 -C 3 )alkoxycarbonyl, (C 1 -C 3 )alkylaminocarbonyl, di(C 1 -C 3 )alkylaminocarbonyl, and cyano(C 1 -C 3 )alkyl; or R 2 and R 3 may be joined together with the carbon to which they are attached to form an unsubstituted or substituted, partially unsaturated or saturated 3-, 4-, 5-, 6-, 7- or 8-membered carbocyclic or heterocyclic ring wherein the heterocyclic ring contains from one to three heteroatoms selected from O, N, or S; and the substituents are independently selected from the group consisting of cyano, nitro, halo, aminocarbonyl, aminothiocarbonyl, carboxy, formyl, hydroxy, amino, carbamoyl, (C 1 -C 3 )alkyl, (C 1 -C 3 )haloalkyl, (C 1 -C 3 )alkoxy, (C 1 -C 3 )haloalkoxy, (C 1 -C 3 )alkythio, (C 1 -C 3 )haloalkylthio, (C 1 -C 3 )alkylsulfonyl, (C 1 -C 3 )alkylamino, di(C 1 -C 3 )alkylamino, (C 1 -C 2 )alkoxy(C 1 -C 2 )alkyl, (C 1 -C 2 )alkylthio(C 1 -C 2 )alkyl, (C 1 -C 2 )alkylsulfonyl(C 1 -C 2 )alkyl, (C 1 -C 2 )alkylamino(C 1 -C 2 )alkyl, di(C 1 -C 2 )alkylamino(C 1 -C 2 )alkyl, (C 1 -C 3 )alkylcarbonyl, (C 1 -C 4 )alkoxycarbonyl, (C 1 -C 4 )alkoxycarbonyl(C 1 -C 4 )alkyl, (C 1 -C 4 )alkoxycarbonylcarbonyl, (C 1 -C 3 )alkylaminocarbonyl, di(C 1 -C 3 )alkylaminocarbonyl, cyano(C 1 -C 3 )alkyl, oxo, methoxyimino, and spiro-(C 1 -C 4 )alkadioxy; and R 4 is unsubstituted or substituted phenyl or pyridyl, wherein the substituents are independently selected from the group consisting of cyano, nitro, halo, aminocarbonyl, aminothiocarbonyl, carboxy, formnyl, hydroxy, amino, carbamoyl, (C 1 -C 6 )alkyl, (C 3 -C 6 )cycloalkyl, (C 1 -C 6 )haloalkyl, (C 3 -C 6 )halocycloalkyl, (C 2 -C 6 )alkenyl, (C 3 -C 6 )cycloalkenyl, (C 3 -C 6 )alkadienyl, (C 2 -C 6 )alkynyl, (C 1 -C 6 )alkoxy, (C 3 -C 6 )cycloalkoxy, (C 1 -C 6 )haloalkoxy, (C 3 -C 6 )cyclohaloalkoxy, (C 2 -C 6 )alkenyloxy, (C 2 -C 6 )alkynyloxy, (C 1 -C 6 )alkythio, (C 3 -C 6 )cycloalkylthio, (C 1 -C 6 )haloalkylthio, (C 3 -C 6 )halocycloalkythio, (C 2 -C 6 )alkenylthio, (C 2 -C 6 )alkynylthio, (C 1 -C 6 )alkylsulfinyl, (C 3 -C 6 )cycloalkysulfinyl, (C 1 -C 6 )haloalkylsulfinyl, (C 3 -C 6 )halocycloalkylsulfinyl, (C 2 -C 6 )alkenylsulfinyl, (C 3 -C 6 )cycloalkenylsulfinyl, (C 2 -C 6 )alkynylsulfinyl, (C 1 -C 6 )alkylsulfonyl, (C 3 -C 6 )cycloalkysulfonyl, (C 1 -C 6 )haloalkylsulfonyl, (C 3 -C 6 )halocycloalkylsulfonyl, (C 1 -C 6 )alkylsulfinyl, (C 3 -C 6 )cycloalkysulfinyl, (C 1 -C 6 )haloalkylsulfinyl, (C 3 -C 6 )halocycloalkylsulfinyl, (C 1 -C 6 )alkylamino, (C 3 -C 6 )cycloalkylamino, di(C 1 -C 6 )alkylamino, di(C 3 -C 6 )(cycloalkyl)amino, (C 1 -C 6 )alkoxy(C 1 -C 6 )alkyl, (C 3 -C 6 )cycloalkoxyalkyl, (C 1 -C 6 )alkoxy(C 3 -C 6 )cycloalkyl, (C 1 -C 6 )alkylthio(C 1 -C 6 )alkyl, (C 1 -C 6 )alkylsulfinyl(C 1 -C 6 )alkyl, (C 1 -C 6 )alkylsulfonyl(C 1 -C 6 )alkyl, (C 1 -C 6 )alkylamino(C 1 -C 6 )alkyl, di(C 1 -C 6 )alkylamino(C 1 -C 6 )alkyl, (C 1 -C 6 )alkylcarbonyl, (C 3 -C 6 )cycloalkylcarbonyl, (C 1 -C 6 )alkoxycarbonyl, (C 1 -C 6 )alkylaminocarbonyl, (C 3 -C 6 )cycloalkylaminocarbonyl, di(C 1 -C 6 )alkylaminocarbonyl, di(C 3 -C 6 )(cycloalkyl)aminocarbonyl, cyano(C 1 -C 6 )alkyl, and tri(C 1 -C 6 )alkylsilyl; wherein in said substituted phenyl or pyridyl, two adjacent substituted positions may be joined together with the atoms to which they are attached to form an unsubstituted or substituted, unsaturated, partially unsaturated, or saturated 4-, 5-, 6- or 7-membered carbocyclic or heterocyclic ring wherein the heterocyclic ring contains from one to three heteroatoms selected from N, O, or S; and the substituents are independently selected from the group consisting of cyano, nitro, halo, aminocarbonyl, aminothiocarbonyl, carboxy, fonnuyl, hydroxy, amino, carbamoyl, (C 1 -C 3 )alkyl, (C 1 -C 3 )haloalkyl, (C 1 -C 3 )alkoxy, (C 1 -C 3 )haloalkoxy, (C 1 -C 3 )alkythio, (C 1 -C 3 )haloalkylthio, (C 1 -C 3 )alkylsulfonyl, (C 1 -C 3 )alkylamino, di(C 1 -C 3 )alkylamino, (C 1 -C 2 )alkoxy(C 1 -C 2 )alkyl, (C 1 -C 2 )alkylthio(C 1 -C 2 )alkyl, (C 1 -C 2 )alkylsulfonyl(C 1 -C 2 )alkyl, (C 1 -C 2 )alkylamino(C 1 -C 2 )alkyl, di(C 1 -C 2 )alkylamino(C 1 -C 2 )alkyl, (C 1 -C 3 )alkylcarbonyl, (C 1 -C 3 )alkoxycarbonyl, (C 1 -C 3 )alkylaminocarbonyl, di(C 1 -C 3 )alkylaminocarbonyl, cyano(C 1 -C 3 )alkyl, oxo, and methoxyimino. 2. The compound of claim 1 wherein: Q 1 is O; and R 4 is unsubstituted or substituted phenyl or pyridyl, wherein the substituents are independently selected from the group consisting of cyano, nitro, halo, carboxy, formyl, hydroxy, amino, (C 1 -C 3 )alkyl, (C 1 -C 3 )haloalkyl, (C 1 -C 3 )alkoxy, (C 1 -C 3 )haloalkoxy, (C 3 )alkenyloxy, (C 3 )alkynyloxy, (C 1 -C 3 )alkythio, (C 1 -C 3 )haloalkylthio, (C 1 -C 3 )alkylsulfinyl, (C 1 -C 3 )haloalkylsulfinyl, (C 1 -C 3 )alkylsulfonyl, (C 1 -C 3 )haloalkylsulfonyl, (C 1 -C 3 )alkylamino, di(C 1 -C 3 )alkylamino, (C 1 -C 2 )alkoxy(C 1 -C 2 )alkyl, (C 1 -C 2 )alkylthio(C 1 -C 2 )alkyl, (C 1 -C 2 )alkylsulfinyl(C 1 -C 2 )alkyl, (C 1 -C 2 )alkylsulfonyl(C 1 -C 2 )alkyl, (C 1 -C 2 )alkylamino(C 1 -C 2 )alkyl, di(C 1 -C 2 )alkylamino(C 1 -C 2 )alkyl, (C 1 -C 3 )alkylcarbonyl, (C 1 -C 3 )alkoxycarbonyl, (C 1 -C 3 )alkylaminocarbonyl, di(C 1 -C 3 )alkylaminocarbonyl, and cyano(C 1 -C 3 )alkyl; wherein in said substituted phenyl or pyridyl, two adjacent positions may be joined together with the atoms to which they are attached to form an unsubstituted or substituted, unsaturated, partially unsaturated, or saturated 4-,5-, 6- or 7-membered carbocyclic or heterocyclic ring wherein the heterocyclic ring contains from one to three heteroatoms selected from N, O, or S; and the substituents are independently selected from the group consisting of cyano, nitro, halo, aminocarbonyl, amin

Assignees

Inventors

Classifications

  • attached in position 4 · CPC title

  • having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring · CPC title

  • Nitrogen atoms (nitro radicals C07D211/38) · CPC title

  • Ethylenedioxybenzenes, not substituted on the hetero ring · CPC title

  • having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9802936B2 cover?
This invention relates to a method to modulate exogenous gene expression in which an ecdysone receptor complex comprising: a DNA binding domain; a ligand binding domain; a transactivation domain; and a ligand is contacted with a DNA construct comprising: the exogenous gene and a response element; wherein the exogenous gene is under the control of the response element and binding of the DNA bind…
Who is the assignee on this patent?
Tice Colin M, Michelotti Enrique L, Hormann Robert E, and 1 more
What technology area does this patent fall under?
Primary CPC classification C07D487/04. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Oct 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).